← All stocks

Zymeworks Inc.

ZYME No buying or selling
CIK 0001937653 #2095 in the set updated 18 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

7 insiders · 0 transactions
7.8×

Kenneth Galbraith holds 7.8 times base salary in stock. $5.14M of shares against $654.83K in salary for 2024.

Salary from the company's own proxy. The shares are what Kenneth Galbraith last reported holding, valued at $22.67, the price Common Stock was last bought or sold at on the open market here, on 12 Jan 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
EcoR1 Capital, LLC entity
Director
22,970,388
$520.82M
+56.3%
Ciongoli Gregory Austin
Director
488,500
$11.08M
+564.6%
Galbraith Kenneth
Chair & CEO
226,842
$5.14M
+854.6%
Hollywood Mark
EVP & Chief Operating Officer
133,852
$3.03M
+10.3%
Moore Paul Andrew
Chief Scientific Officer
48,497
$1.10M
+558.3%
Smith Jeffrey T L
EVP & Chief Medical Officer
26,708
$605.56K
PATTERSON LEONE D
EVP, Chief Bus & Fin Officer
459
$10.41K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 17 Oct 2022